Artivion (AORT) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 662.00 |
| Dec 31, 2025 | 577.00 |
| Sep 30, 2025 | 1,264.00 |
| Jun 30, 2025 | 1,195.00 |
| Mar 31, 2025 | 993.00 |
| Dec 31, 2024 | -1,014.00 |
| Sep 30, 2024 | 14.00 |
| Jun 30, 2024 | -633.00 |
| Mar 31, 2024 | 1,556.00 |
| Dec 31, 2023 | 825.00 |
| Sep 30, 2023 | -1,398.00 |
| Jun 30, 2023 | -278.00 |
| Mar 31, 2023 | 43.00 |
| Dec 31, 2022 | 1,820.00 |
| Sep 30, 2022 | -1,636.00 |
| Jun 30, 2022 | -1,277.00 |
| Mar 31, 2022 | -702.00 |
| Dec 31, 2021 | -2,861.00 |
| Sep 30, 2021 | 55.00 |
| Jun 30, 2021 | -1,108.00 |
| Mar 31, 2021 | -2,041.00 |
| Dec 31, 2020 | 259.00 |
| Sep 30, 2020 | -1,421.00 |
| Jun 30, 2020 | -933.00 |
| Mar 31, 2020 | -701.00 |
| Dec 31, 2019 | -1,129.00 |
| Sep 30, 2019 | -941.00 |
| Jun 30, 2019 | -305.00 |
| Mar 31, 2019 | -731.00 |
| Dec 31, 2018 | -4,521.00 |
| Sep 30, 2018 | -951.00 |
| Jun 30, 2018 | -835.00 |
| Mar 31, 2018 | -1,971.00 |
| Dec 31, 2017 | 1,472.00 |
| Sep 30, 2017 | -780.00 |
| Jun 30, 2017 | -822.00 |
| Mar 31, 2017 | -102.00 |
| Dec 31, 2016 | -107.00 |
| Sep 30, 2016 | 274.00 |
| Jun 30, 2016 | -465.00 |
| Mar 31, 2016 | 569.00 |
| Dec 31, 2015 | -1,339.00 |
| Sep 30, 2015 | 2,392.00 |
| Jun 30, 2015 | -1,687.00 |